Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wajiha Khan is active.

Publication


Featured researches published by Wajiha Khan.


Archive | 2001

SAR of Melanin-concentration Hormone (MCH), an Important Regulatory Hormone in Feeding Behavior

Waleed Danho; Joseph Swistok; Wajiha Khan; Theresa Truitt; Anthony Aglione; Ralph Garippa; Kui Xu; Yingsi Chen; Qing Xiang; Jarema Peter Kochan; Fiorenza Falcioni

Melanin-concentrating hormone is a cyclic hypothalamic neuropeptide [NH2-Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val-COOH cyclo Cys-Cys (7–16)] that was first characterized in chum salmon pituitary as a hormone responsible for color changes in response to environmental stimuli [1]. In mammals, MCH appears to have evolved into an important regulatory hormone in feeding behavior [2]. The MCH peptide is expressed in the hypothalamus, a region involved in energy balance and food intake. In the hypothalamus, MCH mRNA is overexpressed and upregulated during fasting in ob/ob mice and rats. Intra-cerebroventricular injections of MCH promote feeding in mice and rats. Transgenic mice (Tg) lacking the MCH gene are lean and hypophagic, while Tg mice overexpressing MCH in the hypothalamus are hyperphagic, obese, and insulin resistant. Consequently, a potent MCH antagonist is regarded as potentially useful in therapeutic approaches to obesity management. Efforts to identify the ligands for orphan GPCRs have recently led to the discovery of the receptor for MCH [3,4]. Receptor cloning and identification of functional assays for MCHR1 receptor allow the study of receptor/ligand interaction. One possible strategy consists of chemical modifications of the natural ligand (MCH) including: N- and C-termini truncations, Ala substitutions, D-amino acid replacements, and ring size variations, with the goal to identify the critical amino acid residues responsible for agonist or antagonist activity. Here, we describe a detailed SAR of MCH peptides on MCHR1.


Advances in Experimental Medicine and Biology | 2009

Opportunities and challenges of developing peptide drugs in the pharmaceutical industry.

Waleed Danho; Joseph Swistok; Wajiha Khan; Xin-Jie Chu; Adrian Wai-Hing Cheung; David C. Fry; Hongmao Sun; Grazyna Kurylko; Leonid Rumennik; Joseph Cefalu; Gretchen Cefalu; Philip Nunn


Archive | 2006

Neuropeptide-2 receptor-agonists

Karin Conde-Knape; Waleed Danho; George Ehrlich; Nader Fotouhi; David C. Fry; Wajiha Khan; Anish Konkar; Cristina M. Rondinone; Joseph Swistok; Rebecca Taub; Jefferson Wright Tilley


Archive | 2009

Neuropeptide-2 receptor (y-2r) agonists and uses thereof

Karin Conde-Knape; Waleed Danho; George Ehrlich; Nader Fotouhi; David C. Fry; Wajiha Khan; Anish Konkar; Cristina M. Rondinone; Joseph Swistok; Rebecca Taub; Jefferson Wright Tilley


Archive | 2006

Peptides with neuropeptide-2 receptor (y2r) agonist activity

Waleed Danho; George Ehrlich; David C. Fry; Wajiha Khan; Joseph Swistok


Archive | 2009

Neuropeptide-2 receptor (y-2r) agonists

Waleed Danho; David C. Fry; Robert Alan Goodnow; Wajiha Khan; Joseph Swistok; Jefferson Wright Tilley


Archive | 2007

Analogs of vasoactive intestinal peptide

David Robert Bolin; Wajiha Khan; Hanspeter Michel


Archive | 2011

GLUCOSE-DEPENDENT INSULINOTROPIC PEPTIDE ANALOGS

Waleed Danho; George Ehrlich; Wajiha Khan; Joseph Swistok; Jefferson Wright Tilley


Archive | 2007

NOVEL ANALOGS OF VASOACTIVE INTESTINAL PEPTIDE

David Robert Bolin; Wajiha Khan; Hanspeter Michel


Archive | 2014

CELL PENETRATING PEPTIDES TO TARGET EIF4E

Waleed Danho; Nader Fotouhi; Yi Han; Wajiha Khan; Francesca Milletti; Huifeng Nui

Collaboration


Dive into the Wajiha Khan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge